to BioTechniques free email alert service to receive content updates.
Molecular Biology
TruSeq sample preparation kits
Illumina's TruSeq sample preparation kits for DNA, RNA, and small RNA applications and the TruSeq Exome Enrichment Kit are designed to provide a streamlined workflow that is economical and scalable, delivering accuracy for sequencing studies.
TruSeq Sample Prep kits feature master-mixed reagents and optimized adapter design, making sequencing workflows easier. TruSeq Exome Enrichment kits, used with TruSeq DNA Sample Prep kits, enable large-scale exome studies using a pre-enrichment pooling approach with plate-based processing of up to 96 samples. TruSeq solutions provide: • Coverage of greater than 62 Mb of the human exome, with an industry-leading price of less than $300 per sample enrichment. • A flexible approach for single-end, paired-end, and multiplexed sequencing with as much as 80% reduction in price for sample prep. • Sequencing-based gene expression studies with richer data sets, a simpler workflow, and a lower price than arrays. • A means for researchers to combine up to 48 samples into a single sequencing lane, profiling the whole spectrum of small RNAs with the highest sensitivity and specificity.
 
This Product is made by:

About Illumina
Illumina is the leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients.

Illumina, Inc.
9885 Towne Centre Drive
San Diego, CA 92121 USA
1.800.809.4566 toll-free
1.858.202.4566 outside North America
1.858.202.4766 fax
Email: [email protected]
Web site: http://www.illumina.com